Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW

References

• Chaichana KL, Jusue-Torres I, Navarro-Ramirez R, et al. Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma. Neuro Oncol 2014;16:113–22.
   PubMed Web of Science ®Google Scholar
• Lacroix M, Abi-Said D, Fourney DR, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: Prognosis, extent of resection, and survival. J Neurosurg 2001;95:190–8.
   PubMed Web of Science ®Google Scholar
• Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS. An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 2011;115:3–8.
   PubMed Web of Science ®Google Scholar
• Bloch O, Han SJ, Cha S, et al. Impact of extent of resection for recurrent glioblastoma on overall survival: Clinical article. J Neurosurg 2012;117:1032–8.
   PubMed Web of Science ®Google Scholar
• Giese A, Bjerkvig R, Berens ME, Westphal M. Cost of migration: Invasion of malignant gliomas and implications for treatment. J Clin Oncol 2003;21:1624–36.
   PubMed Web of Science ®Google Scholar
• Goebell E, Fiehler J, Ding XQ, et al. Disarrangement of fiber tracts and decline of neuronal density correlate in glioma patients–a combined diffusion tensor imaging and 1H-MR spectroscopy study. AJNR Am J Neuroradiol 2006;27:1426–31.
   PubMed Web of Science ®Google Scholar
• Engelhorn T, Savaskan NE, Schwarz MA, et al. Cellular characterization of the peritumoral edema zone in malignant brain tumors. Cancer Sci 2009;100:1856–62.
   PubMed Web of Science ®Google Scholar
• Keles GE, Lamborn KR, Berger MS. Low-grade hemispheric gliomas in adults: A critical review of extent of resection as a factor influencing outcome. J Neurosurg 2001;95:735–45.
   PubMed Web of Science ®Google Scholar
• Johannesen TB, Langmark F, Lote K. Progress in long-term survival in adult patients with supratentorial low-grade gliomas: A population-based study of 993 patients in whom tumors were diagnosed between 1970 and 1993. J Neurosurg 2003;99:854–62.
   PubMed Web of Science ®Google Scholar
• Cortnum S, Laursen RJ. Fluorescence-guided resection of gliomas. Dan Med J 2012;59:A4460.
   Google Scholar
• Tykocki T, Michalik R, Bonicki W, Nauman P. Fluorescence-guided resection of primary and recurrent malignant gliomas with 5-aminolevulinic acid. Preliminary results.Neurol Neurochir Pol 2012;46:47–51.
   PubMed Web of Science ®Google Scholar
• Stummer W, Pichlmeier U, Meinel T, et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: A randomised controlled multicentre phase III trial. Lancet Oncol 2006;7:392–401.
   PubMed Web of Science ®Google Scholar
• Aldave G, Tejada S, Pay E, et al. Prognostic value of residual fluorescent tissue in glioblastoma patients after gross total resection in 5-aminolevulinic Acid-guided surgery. Neurosurgery 2013;72:915–20.
   PubMed Web of Science ®Google Scholar
• Heimberger AB, Hlatky R, Suki D, et al. Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients. Clin Cancer Res 2005;11:1462–6.
   PubMed Web of Science ®Google Scholar
• Bredel M, Pollack IF, Hamilton RL, James CD. Epidermal growth factor receptor expression and gene amplification in high-grade non-brainstem gliomas of childhood. Clin Cancer Res 1999;5: 1786–92.
   PubMed Web of Science ®Google Scholar
• Gan HK, Kaye AH, Luwor RB. The EGFRvIII variant in glioblastoma multiforme. J Clin Neurosci 2009;16:748–54.
   PubMed Web of Science ®Google Scholar
• Day KE, Beck LN, Deep NL, et al. Fluorescently labeled therapeutic antibodies for detection of microscopic melanoma. Laryngoscope 2013;123:2681–9.
   PubMed Web of Science ®Google Scholar
• Day KE, Beck LN, Heath CH, et al. Identification of the optimal therapeutic antibody for fluorescent imaging of cutaneous squamous cell carcinoma. Cancer Biol Ther 2013;14:271–7.
   PubMed Web of Science ®Google Scholar
• Day KE, Sweeny L, Kulbersh B, Zinn KR, Rosenthal EL. Preclinical comparison of near-infrared-labeled cetuximab and panitumumab for optical imaging of head and neck squamous cell carcinoma. Mol Imaging Biol 2013;15:722–9.
   PubMed Web of Science ®Google Scholar
• Heath CH, Deep NL, Sweeny L, Zinn KR, Rosenthal EL. Use of panitumumab-IRDye800 to image microscopic head and neck cancer in an orthotopic surgical model. Ann Surg Oncol 2012;19:3879–87.
   PubMed Web of Science ®Google Scholar
• Kim GP, Grothey A. Targeting colorectal cancer with human anti-EGFR monoclonocal antibodies: Focus on panitumumab. Biologics 2008;2:223–8.
   PubMedGoogle Scholar
• Kulbersh BD, Duncan RD, Magnuson JS, et al. Sensitivity and specificity of fluorescent immunoguided neoplasm detection in head and neck cancer xenografts. Arch Otolaryngol Head Neck Surg 2007;133;511–5.
   PubMedGoogle Scholar
• Newman JR, Gleysteen JP, Baranano CF, et al. Stereomicroscopic fluorescence imaging of head and neck cancer xenografts targeting CD147. Cancer Biol Ther 2008 ;7:1063–70.
   PubMed Web of Science ®Google Scholar
• Rosenthal EL, Kulbersh BD, Duncan RD, et al. In vivo detection of head and neck cancer orthotopic xenografts by immunofluorescence. Laryngoscope 2006;116:1636–41.
   PubMed Web of Science ®Google Scholar
• Rosenthal EL, Kulbersh BD, King T, Chaudhuri TR, Zinn KR. Use of fluorescent labeled anti-epidermal growth factor receptor antibody to image head and neck squamous cell carcinoma xenografts. Mol Cancer Ther 2007;6:1230–8.
   PubMed Web of Science ®Google Scholar
• Korb ML, Hartman YE, Kovar J, et al. Use of monoclonal antibody-IRDye800CW bioconjugates in the resection of breast cancer. J Surg Res 2014;188:119–28.
   PubMed Web of Science ®Google Scholar
• Tate MC, Aghi MK. Biology of angiogenesis and invasion in glioma. Neurotherapeutics 2009;6:447–57.
   PubMed Web of Science ®Google Scholar
• Han M, Wang H, Zhang HT, Han Z. Expression of Tax-interacting protein 1 (TIP-1) facilitates angiogenesis and tumor formation of human glioblastoma cells in nude mice. Cancer Lett 2013;328: 55–64.
   PubMed Web of Science ®Google Scholar
• Lee CG, Heijn M, di Tomaso E, et al. Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Cancer Res 2000;60: 5565–70.
   PubMed Web of Science ®Google Scholar
• Ricard C, Stanchi F, Rodriguez T, et al. Dynamic quantitative intravital imaging of glioblastoma progression reveals a lack of correlation between tumor growth and blood vessel density. PLoS One 2013;8:e72655.
   Google Scholar
• Nguyen QT, Olson ES, Aguilera TA, et al. Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival. Proc Natl Acad Sci USA 2010;107:4317–22.
   PubMed Web of Science ®Google Scholar
• Huang R, Vider J, Kovar JL, et al. Integrin alphavbeta3-targeted IRDye 800CW near-infrared imaging of glioblastoma. Clin Cancer Res 2012;18:5731–40.
   PubMed Web of Science ®Google Scholar
• Kaushal S, McElroy MK, Luiken GA, et al. Fluorophore-conjugated anti-CEA antibody for the intraoperative imaging of pancreatic and colorectal cancer. J Gastrointest Surg 2008;12:1938–50.
   PubMed Web of Science ®Google Scholar
• Combs SE, Heeger S, Haselmann R, et al. Treatment of primary glioblastoma multiforme with cetuximab, radiotherapy and temozolomide (GERT) –phase I/II trial: Study protocol. BMC Cancer 2006;6:133.
   PubMed Web of Science ®Google Scholar
• Marshall MV, Draney D, Sevick-Muraca EM, Olive DM. Single-dose intravenous toxicity study of IRDye 800CW in Sprague–Dawley rats. Mol Imaging Biol 2010;12:583–94.
   PubMed Web of Science ®Google Scholar
• Hatanpaa KJ, Burma S, Zhao D, Habib AA. Epidermal growth factor receptor in glioma: Signal transduction, neuropathology, imaging, and radioresistance. Neoplasia 2010;12:675–84.
   PubMed Web of Science ®Google Scholar
• Ohgaki H, Kleihues P. Genetic pathways to primary and secondary glioblastoma. Am J Pathol 2007;170:1445–53.
   PubMed Web of Science ®Google Scholar